Effects of glucose-induced insulin secretion on ventricular repolarization in patients with congenital long QT syndrome.
To assess the role of insulin in ventricular repolarization in patients with congenital long QT syndrome (LQTS), an oral glucose tolerance (OGT) test was performed in 11 patients with LQTS and in 11 control cases without QT prolongation. Plasma glucose, potassium level and the immunoreactive insulin concentration (IRI) were measured, and the QT interval and T wave morphology on 12-lead ECG were analyzed during fasting and after glucose load. The LQTS group had a higher incidence of changes in T wave morphology, such as biphasic, bifid or notched T wave, after glucose load than the control group (11 of 11 patients [100%] vs 0 of 11 [0%]; p<0.00001). The T wave changes returned to baseline at 180 min after glucose load in 7 patients. The maximal QT interval and QT dispersion increased significantly and returned to baseline level in response to IRI after glucose load in LQTS, whereas the QT interval was unaffected in the control group. After glucose load, ventricular arrhythmias and T wave alternans were observed in 3 and 1 patients with LQTS, respectively, but none in the control group. The findings suggest that glucose-induced insulin secretion plays a role in inducing abnormalities and inhomogeneity of ventricular repolarization in patients with LQTS.
Nishizaki
Mitsuhiro
M
Department of Cardiology, Yokohama Minami Kyosai Hospital, Kanagawa, Japan. nisizaki@yhb.att.ne.jp
Ashikaga
Takashi
T
Yamawake
Noriyoshi
N
Fujii
Hiroyuki
H
Arita
Masataka
M
Sumitomo
Naokata
N
Sakurada
Harumizu
H
Hiraoka
Masayasu
M
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008133:Long QT Syndrome / Q000151:congenital* / Q000503:physiopathology*; D008297:Male; D008801:Mexiletine / Q000627:therapeutic use; D011188:Potassium / Q000097:blood; D012016:Reference Values; D016276:Ventricular Function / Q000187:drug effects / Q000502:physiology*
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D007328:Insulin; D008801:Mexiletine; D005947:Glucose; D011188:Potassium